Decorin fragments inhibiting cell regulatory factors
AssigneeLa Jolla Cancer Research Foundation
InventorsErkki I. Ruoslahti, Michael D. Pierschbacher, Jose Cardenas, William Craig, Daniel G. Mullen
Life of this patent
Estimating the term…
Loading patent…
AssigneeLa Jolla Cancer Research Foundation
InventorsErkki I. Ruoslahti, Michael D. Pierschbacher, Jose Cardenas, William Craig, Daniel G. Mullen
Estimating the term…
The present invention provides a method of inhibiting an activity of a cell regulatory factor comprising contacting the cell regulatory factor with a purified polypeptide, wherein the polypeptide comprises a cell regulatory factor binding domain of a protein. The protein is characterized by a leucine-rich repeat of about 24 amino acids. In a specific embodiment, the present invention relates to the ability of decorin, a 40,000 dalton protein that usually carries a glycosaminoglycan chain, and more specifically to active fragments of decorin or its functional equivalents to bind TGF.beta.. The invention also provides a novel cell regulatory factor designated MRF. Also provided are methods of identifying, detecting and purifying cell regulatory factors and proteins which bind and affect the activity of cell regulatory factors.
A polypeptide comprising the sequence His-Leu-Arg-Val-Val-Gln (SEQ ID NO:
A polypeptide whose amino acid sequence is:
A polypeptide whose amino acid sequence is:
Dependencies are inferred from the claim text.